Tan Michelle M C, Jin Xingzhong, Taylor Craig, Low Adrian K, Le Page Philip, Martin David, Li Ang, Joseph David, Kormas Nic
Boden Initiative, Central Clinical School, Sydney School of Medicine, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Department of Endocrinology & Metabolism, Concord Repatriation General Hospital, Sydney Local Health District, Concord, NSW 2139, Australia.
J Clin Med. 2022 Jul 31;11(15):4466. doi: 10.3390/jcm11154466.
Background: Real-world data on long-term (> 5 years) weight loss and obesity-related complications after newer bariatric surgical procedures are currently limited. The aim of this longitudinal study was to examine the effectiveness and sustainability of bariatric surgery in a cohort with clinically severe obesity in a multidisciplinary publicly funded service in two teaching hospitals in New South Wales, Australia. Methods: Patients were adults with complex clinically severe obesity with a BMI ≥ 35 kg/m2 and at least three significant obesity-related comorbidities, who underwent bariatric surgeries between 2009 and 2017. Detailed obesity-related health outcomes were reported from annual clinical data and assessments for up to 9 years of follow-up. Data were also linked with the national joint replacement registry. Results: A total of 65 eligible patients were included (mean, 7; range, 3−12 significant obesity-related comorbidities); 53.8% female; age 54.2 ± 11.2 years, with baseline BMI 52.2 ± 12.5 kg/m2 and weight 149.2 ± 45.5 kg. Most underwent laparoscopic sleeve gastrectomy (80.0%), followed by laparoscopic adjustable gastric banding (10.8%) and one anastomosis gastric bypass (9.2%). Substantial weight loss was maintained over 9 years of follow-up (p < 0.001 versus baseline). Significant total weight loss (%TWL ± SE) was observed (13.2 ± 2.3%) following an initial 1-year preoperative intensive lifestyle intervention, and ranged from 26.5 ± 2.3% to 33.0 ± 2.0% between 1 and 8 years following surgery. Type 2 diabetes mellitus (T2DM), osteoarthritis-related joint pain and depression/severe anxiety were the most common metabolic, mechanical and mental health comorbidities, with a baseline prevalence of 81.5%, 75.4% and 55.4%, respectively. Clinically significant composite cumulative rates of remission and improvement occurred in T2DM (50.0−82.0%) and hypertension (73.7−82.9%) across 6 years. Dependence on continuous positive airway pressure treatment in patients with sleep-disordered breathing fell significantly from 63.1% to 41.2% in 6 years. Conclusion: Bariatric surgery using an intensive multidisciplinary approach led to significant long-term weight loss and improvement in obesity-related comorbidities among the population with clinically complex obesity. These findings have important implications in clinical care for the management of the highest severity of obesity and its medical consequences. Major challenges associated with successful outcomes of bariatric surgery in highly complex patients include improving mental health in the long run and reducing postoperative opioid use. Long-term follow-up with a higher volume of patients is needed in publicly funded bariatric surgery services to better monitor patient outcomes, enhance clinical data comparison between services, and improve multidisciplinary care delivery.
目前,关于新型减肥手术后长期(>5年)体重减轻及肥胖相关并发症的真实世界数据有限。本纵向研究的目的是在澳大利亚新南威尔士州两家教学医院的多学科公共资助服务中,检验减肥手术对临床重度肥胖队列的有效性和可持续性。方法:患者为患有复杂临床重度肥胖的成年人,BMI≥35kg/m²,且至少有三种与肥胖相关的严重合并症,于2009年至2017年间接受减肥手术。通过年度临床数据和评估报告详细的肥胖相关健康结局,随访时间长达9年。数据还与国家关节置换登记处相关联。结果:共纳入65例符合条件的患者(平均7种;范围3 - 12种与肥胖相关的严重合并症);53.8%为女性;年龄54.2±11.2岁,基线BMI为52.2±12.5kg/m²,体重149.2±45.5kg。大多数患者接受了腹腔镜袖状胃切除术(80.0%),其次是腹腔镜可调节胃束带术(10.8%)和单吻合口胃旁路术(9.2%)。在9年的随访中体重持续大幅减轻(与基线相比,p<0.001)。在术前进行1年强化生活方式干预后,观察到显著的总体重减轻(%TWL±SE)(13.2±2.3%),术后1至8年体重减轻范围为26.5±2.3%至33.0±2.0%。2型糖尿病(T2DM)、骨关节炎相关关节疼痛和抑郁/重度焦虑是最常见的代谢、机械和心理健康合并症,基线患病率分别为81.5%、75.4%和55.4%。6年间,T2DM(50.0 - 82.0%)和高血压(73.7 - 82.9%)出现了具有临床意义的综合累积缓解率和改善率。睡眠呼吸障碍患者对持续气道正压通气治疗的依赖在6年内从63.1%显著降至41.2%。结论:采用强化多学科方法的减肥手术导致临床复杂肥胖人群长期显著体重减轻,并改善了肥胖相关合并症。这些发现对肥胖及其医学后果最严重程度的临床管理具有重要意义。在高度复杂患者中,减肥手术成功结果面临的主要挑战包括长期改善心理健康和减少术后阿片类药物使用。公共资助的减肥手术服务需要对更多患者进行长期随访,以更好地监测患者结局,加强服务之间的临床数据比较,并改善多学科护理服务。